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1. Introduction 
The properties of the enzyme adenylate cyclase 
are generally studied in membrane fractions, because 
of the apparent unstability of the enzyme during the 
purification steps. Despite this limitation, anumber 
of kinetic features of the enzyme activity are known 
[1,2]. Adenylate cyclase activity is modulated at least 
in part by the binding of guanine nucleotides to a 
regulatory site of the enzyme distinct from the cata- 
lytic site. We show here that the commercial denosine 
triphosphate analogue adenosine-5'-O-thiotriphosphate 
AMP-PPS activates the adenylate cyclase of purified 
calf thymocyte plasma membranes. The stimulatory 
effect produced by this compound isadditive to that 
induced by the GTP analogue GMP-P(NH)P. 
Activation of adenylate cyclase by GMP-P(NH)P 
is known to be a slow, time-dependent process [3-6].  
We show here that not only GMP-P(NH)P, but also 
fluoride, as well as AMP-PPS, activate the calf 
thymocyte plasma membrane enzyme in a time- 
dependent, slow process, which is unrelated to a 
progressive permeabilisation f the closed vesicles to 
the substrate or to the stimulating agents. 
2. Materials and methods 
2.1. Preparation of  the lymphocyte membrane 
fractions 
This was performed as described [7]. The plasma 
membrane pellets were resuspended in TKM buffer 
containing 10 mM dithiothreitol (DTT) and 2.5 mM 
theophyllin. They were used immediately, orstored 
frozen in liquid nitrogen. 
2.2. Adenylate cyclase assay 
The assay was performed according to [8] at 36°C. 
Membrane samples were thawed just before the assay. 
Final concentrations i  the assay were, unless indicated: 
1 mM ATP (containing 1.2-1.8 X l0 s cpm [a.32p]. 
ATP); 1 mM cAMP; 1.25 mM theophylline; 20 mM 
creatine phosphate; 70 units/ml creatine kinase; 
5 mM DTT; 1 mM EGTA; 5 mM MgC12 ; 12.5 mM 
KC1; 50 mM Tris-HCl, pH 7.3; 0.3--0.7 mg/ml mem- 
brane proteins. The assay volume was 100/al/time 
point. The reaction was initiated by the addition of 
labeled ATP, or when preincubation took place, it 
was measured from the time of addition of labeled 
ATP, on. The adenylate cyclase activity was strictly 
proportional to the amount of proteins added. The 
specific activity was measured over time intervals of 
5 min or 10 min, by substracting from each time-point 
value the value determined in the same sample at the 
previous time point. Duplicates agreed within less 
than 5%. All nucleotides and analogues were from 
Sigma and from Boehringer. [o~-32P]ATP (10-20 Ci/ 
mmol) in aqueous olution was from the Radio- 
chemical Centre, Amersham. 
2.3. Radioimmunoassay 
cAMP was extracted from the samples by addition 
of boiling ethanol. The cAMP supematant content 
was determined by radioimmunoassay as in [9], after 
succinylation of the dessicated supematant residue. 
12SI-Labeled succinyl-tyrosyl-methyl ester of cAMP 
and anti-succinyl cAMP antibodies were prepared by 
P. PradeUes, Institut Pasteur. 
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3. Results 
3.1. AMP- PPS-induced activation of adenyla te c yclase 
The ability of adenylate cyclase to use AMP-PPS 
as a substrate was tested by radioimmunoassay 
measurement of the cAMP produced by membranes 
incubated with AMP-PPS (Boehringer) as the sole 
possible substrate. AMP-PPS was found to be a sub- 
strate for adenylate cyclase (table 1). To compare 
AMP-PPS and ATP in this respect, we determined 
the specific activity of the cAMP produced in systems 
in which variable proportions of AMP-PPS and ATP 
were used, by processing the samples in parallel 
according to [8] and to the radioimmunoassay method 
[9]. When ATP was the sole substrate of the reaction, 
the cAMP specific activity measured was close to 
that of ATP. (Experimental error:-+18%) (table 1). 
The cAMP specific radioactivity decreased in inverse 
ratio to that of the AMP-PPS content in the substrate 
mixture (table 1). AMP-PPS was thus roughly com- 
parable to ATP as a substrate for adenylate cyclase. 
Used at 0 .5 -2  mM, AMP-PPS enhanced the 
adenylate cyclase specific activity, as compared to 
that measured in the presence of  equal concentrations 
of ATP, by a factor of 34  (table 2). 
Association of AMP-PPS and GMP-P(NH)P in 
the assay induced an increase in the plateau value of 
the enzyme specific activity which was about the sum 
of the increase produced by each component ( able 2). 
Substrate 
3.2. Kinetics of activation of adenylate cyclase by the 
stimulator2/agents AMP-PPS, GMP-P(NH)P and 
NaF 
In basal conditions and except for the first 2 -10  
min, the production of cAMP was linear for 1 -2  h 
(fig. 1). (If, however, the ATP regenerating system was 
omitted from the incubation medium, the adenylate 
cyclase specific activity decreased linearly with time, 
reaching 50% of the control value after 10 min 
incubation.) 
When AMP-PPS was added to the assay mixture, a
20-30  min accelerating phase in enzyme specific 
activity was observed (fig.l). 
A similar phenomenon of  slow activation of  the 
Table 1 
Assessment of AMP-PPS as a substrate for adenylate cyclase 
cAMP (pm.mg -1 min -I ) ATP cAMP 
RIA Salomon (epm.pm71_) (cpm.pm-I) 
ATP 1.1 mM 9.2 14 13 17 
AMP-PPS 1 mM 57.7 - - - 
AMP-PPS 1 mM + 
ATP 0.1 mM 46 31.3 130 5.5 
ATP 1 mM 17.6 17.4 13 13.9 
AMP-PPS 1 mM + 
ATP 2 vM 62.5 62.7 6500 14.1 a 
AMP-PPS 0.1 mM + 
ATP 2 uM 8.3 6.5 6500 134 
a The very low cAMP specific radioactivity measured in this case may be due to uncertainty in
ATP concentration if, indeed, AMP-PPS (1 mM) is contaminated to some extent by ATP, 
the ATP concentration becomes higher than 2/~M, and its specific radioactivity is conse- 
quently lower 
Membranes were incubated for 20-40 min at 36°C in the assay mixture described in section 2, 
with the following modifications: 12.5 nM cAMP; 0.2 mM isobutylmethylxanthine (Aldrich), 
(expt. 1); or 5 mM theophyllin (expt. 2); and the substrates indicated in the first column. Pro- 
duction of cAMP, in pmol mg- 1. min- 1, was determined by radioimunnoassay (second column 
in this ease, no labeled ATP in the assay) and by the method [8] (third column; in this case, 
radioactive ATP, of various pecific radioactivities, indicated in the fourth column, was used). 
Aliquots, 100 tA, were withdrawn in each case at 10 min intervals, and the specific radioactivity 
of the cAMP produced was determined, and indicated in the fifth column 
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Table 2 
Effects of GMP-P(NH)P and/or AMP-PPS on 
adenylate cyclase 
ATP AMP-PPS GMP-P(NH)P 
Adenylate cyclase 
spec. act. 
(pm.mg- 1. min- t) 
0.6 mM - - 26 
1.1 mM - - 36 
2.1 mM - - 34.5 
0.1 mM 0.5 mM - 85 
0.1 mM 1.0 mM - 139 
0.1 mM 2.0 mM - 200 
1.0 mM - 0.001 mM 271 
1.0 mM - 0.010 mM 290 
1.0 mM - 0.1 mM 264 
0.1 mM 0.5 mM 0.1 mM 316 
0.1 mM 1.0 mM 0.1 mM 406 
0.1 mM 2.0 mM 0.1 mM 454 
Membranes were incubated for 20-50 min at 36°C in the 
assay mixture containing the nucleotides ATP, AMP-PPS 
and/or GMP-P(NH)P at the concentrations i dicated in the 
first three columns. The adenylate cyclase specific activity 
values, (pmol cAMP. mg -1 . min-1) were the plateau values 
(determined after 40-50 min incubation). The concentra- 
tion of AMP-PPS was taken into account for the calcula- 
tion of the enzyme specific activity 
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enzyme was observed in the presence of  NaF. 
Adenylate cyclase was stimulated up to 10-fold by 
the addition of  10 mM NaF, higher concentrations 
of  fluoride progressively leading to a decrease in 
specific activity. Omission of  the ATP regenerating 
system did not affect the fluoride-stimulated, 
adenylate cyclase apparent specific activity, for at 
least 1 h. The specific activity of  adenylate cyclase 
sharply increased upon addition of  NaF to the assay 
mixture until a plateau value was reached within 
30-40  min (fig.l). As a way to increase the perme- 
ability of the membrane vesicles to the components 
of  the assay mixture, membranes were submitted to 
the action of  sodium deoxycholate [10]. To mem- 
branes ubmitted to 0.03% DOC for 20 min in a pre- 
incubation medium containing ATP, fluoride and 
tracer labeled ATP were added together at the onset 
of  incubation. A same 30 rain accelerating phase of 
the enzyme specific activity was still observed, the 
plateau value being 70% that reached in membranes 
preincubated without DOC, and then treated with 
fluoride (table 3). Exactly the same accelerating 
phase and plateau value of  the enzyme specific activity 
(70% control) were observed when preincubation was 
omitted, fluoride, DOC and ATP being added together. 
By analogy with DOC, we studied the effect of ala- 
methicin, a channel forming ionophore (Upjohn Co.) 
[11 ], on the kinetics of adenylate cyclase activation 
by fluoride. Alamethicin, 0.1 #g//ag membrane 
protein, was added to membranes, either in preincuba- 
tion for 20 min with ATP, fluoride being added at the 
onset of incubation, or to non-preincubated mem- 
branes, together with ATP and fluoride. In both cases, 
the alamethicin and fluoride-treated membranes dis- 
played a much higher adenylate cyclase activity than 
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Fig.1. Membranes were incubated at 36°C in an assay medium 
containing 1 mM ATP and the other components li ted in 
Section 2, without any other addition (o o), in the 
presence of 1 mM AMP-PPS (m =), 10raM NaF (* . )  
or 10-SM GMP-P(NH)P (A A). 
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Table 3 
Effect of DOC or of alamethicin on fluoride stimulated adenylate cyclase 
specific activity 
Spec. act. 
(pm. mg -a . min -1) 
Membranes not treated with fluoride 28 
Membranes treated with 10 mM NaF 180 
Membranes treated with NaF 10 mM and 0.03% DOC 126 
Membranes treated with NaF 10 mM and alamethicin 486 
Membranes were incubated for 20-50 min at 37°C in the assay mixture described in
section 2, without addition, or with 10 mM NaF, 0.03% DOC, or alamethicin (0.1 ~g/ 
/~g membrane protein). The adenylate cyclase specific activities refer to the plateau 
values (determined after 40-50 min incubation) 
control membranes (alcohol and fluoride treated) 
(table 3), but exactly the same 30 rain accelerating 
phase in enzyme specific activity was observed in 
alamethicin, and control, fluoride treated membranes. 
In a time-dependent manner very similar to the 
fluoride-induced activation, GMP-P(NH)P stimulated 
adenylate cyclase. The specific activity of the enzyme 
sharply increased for 30--60 min or even longer (fig. 1). 
The plateau value reached was studied as a function 
of GMP-P(NH)P concentration (table 2). The accel- 
erating phase was unchanged over the whole range of 
concentrations studied. 
4. Discussion 
To our knowledge, the enhancement of adenylate 
cyclase specific activity by AMP-PPS has not yet 
been reported. We have shown that this thiotriphos- 
phate analogue of ATP is indeed a substrate for 
adenylate cyclase. It also works as a stimulating agent. 
The question may be raised of a possible contamina- 
tion of the compound by GMP-PPS, which has been 
shown to activate turkey erythrocyte adenylate 
cyclase, in the presence of hormone [12]. Indeed, 
adenosine triphosphate analogues are produced by 
modification of yeast AMP (Boehringer), and unless 
this compound is submitted to several chromatogra- 
phies, it is usually contaminated by traces of GMP. 
Further work is in progress to clarify this point. By 
analogy, we have found that some batches of AMP- 
P(NI-I)P induced a marked increase in adenylate 
cyclase specific activity (unpublished results). In 
such cases, a contamination of the AMP-P(NH)P 
batch by less than 0.1% of GMP-P(NH)P would be 
sufficient o explain the stimulatory effect. Such an 
effect was not additive with that obtained with 
GMP-P(NH)P. On the contrary, in the case of AMP- 
PPS adenylate cyclase stimulation, we have found 
that the AMP-PPS and the GMP-P(NH)P-induced 
effects were additive. If the active compound in the 
AMP-PPS batch was to be GMP-PPS, this observa- 
tion would suggest that GMP-PPS and GMP-P(NH)P, 
although being probably bound by the same subunit, 
have different and cooperative effects on the enzyme - 
if, indeed, their target is the enzyme. However, the 
active compound may actually be AMP-PPS, binding 
to the catalytic site or any adenosine nucleotide bind- 
ing site. In this case, the additivity of the effects of 
AMP-PPS and GMP-P(NH)P would not be a problem 
'per se'. Although a dephosphorylation f the enzyme 
has been proposed as a mechanism of activation [13], 
it is tempting to speculate, in the case of AMP-PPS, 
on a thiophosphorylation of the enzyme, which would 
in some way mimic a very stable phosphorylation. 
The conditions chosen for the adenylate cyclase assay 
were indeed conditions for which some membrane 
proteins of our thymocyte plasma membranes were 
phosphorylated (unpublished results). Phosphorylation, 
or thiophosphorylation, f adenylate cyclase is thus 
not excluded. 
As long as the mechanism by which AMP-PPS 
activates adenylate cyclase remains unknown, it is 
difficult to speculate on the 'lag' phase observed upon 
establishment of the activated state. However, very 
similar kinetics of activation were observed when 
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GMP-P(NH)P or fluoride were used as stimulating 
agents. A progressive permeabilisation f the closed 
vesicles to the substrate and stimulatory compounds 
was first considered. In the case studied here, the mem- 
brane fragments were completely closed vesicles [7], 
and their polarity was mostly right-side out, as plasma 
membranes ctoenzymes were detected without any 
latency [7]. The catalytic site of the adenylate cyelase 
thus faced the inside of the vesicles. If a progressive 
permeabilisation f the vesicles accounted for the ` lag' 
phase observed, then an alteration oft.he vesicles making 
them freely permeable to the compounds present in 
the assay should abolish this 'lag' phase. On the con- 
trary, we have shown that this lag phase was not 
shortened by treatment of membranes with a deter- 
gent, or with the channel-forming ionophore, ale- 
methicin. The stimulating agents thus did not provoke 
an instant increase in enzyme specific activity, even 
when vesicles were freely permeable to molecules of 
small size. Such a fact was known for GMP-P(NH)P 
adenylate cyclase stimulation [3-6] but had not yet, 
to our knowledge, been reported in the case of fluoride 
or AMP-PPS activation of the enzyme, or not yet 
been recognized as such, most probably because the 
linearity of the reaction with time had not been assess- 
ed on a sufficient ime range [14,15]. The 'lag' phase 
observed upon activation of adenylate cydase by 
AMP-PPS, GMP-P(NH)P or NaF thus seems to be 
explained by progressive, physical or chemical, modi- 
fication(s) of the enzyme at the level of the catalytic 
site. However, it must be stressed that the enzyme is 
studied here not as an isolated, purified molecule, but 
as a component of intact membrane vesicles. This 
membranous environment may well play a major role 
on the adenylate cyclase state of activity. 
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